Paul Gallo

Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

Hajime Uno, Brian Claggett, Lü Tian et al. · Journal of Clinical Oncology · 2014 · 721 citations · Full text

Retrospective Cohort Study, Between-group Difference, Cancer Epidemiology +15

Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group

Paul Gallo, Christy Chuang‐Stein, Vladimir Dragalin et al. · Journal of Biopharmaceutical Statistics · 2006 · 305 citations

White Paper, Optimal Experimental Design, Pharmacotherapy +18

Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology

Werner Brannath, Emmanuel Zuber, Michael Branson et al. · Statistics in Medicine · 2009 · 190 citations

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Marc A. Pfeffer, John J.V. McMurray, Alain Leizorovicz et al. · American Heart Journal · 2000 · 182 citations

Cardiovascular Disease, Pharmacotherapy, Acute Myocardial Infarction +5

Adaptive Seamless Phase II/III Designs—Background, Operational Aspects, and Examples

Jeff Maca, Sumon Bhattacharya, Vladimir Dragalin et al. · Drug Information Journal · 2006 · 144 citations

Engineering, Circuit Design, Numerical Simulation +6